中國聖牧(01432.HK):中國蒙牛增持12.48%股份 持股增至29.99%
格隆匯7月6日丨中國聖牧(01432.HK)發佈公吿,公司獲吿知於2021年7月6日公司一名主要股東及單一最大股東Start Great收購公司共1,045,985,065股股份,佔於該公吿日期公司全部已發行股本約12.48%。
緊隨收購事項後,Start Great持有的股份數目將從1,467,193,490股股份(佔公司全部已發行股本約17.51%)增至2,513,178,555股股份(佔於該公吿日期公司全部已發行股本約29.99%)。由於Start Great為中國蒙牛的全資附屬公司,根據證券及期貨條例第XV部(香港法例第571章),中國蒙牛將被視為於Start Great將擁有權益的2,513,178,555股股份中擁有權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.